These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31175529)

  • 21. Anticoagulation strategies in patients with atrial fibrillation after PCI or with ACS : The end of triple therapy?
    Fluschnik N; Becher PM; Schnabel R; Blankenberg S; Westermann D
    Herz; 2018 Feb; 43(1):20-25. PubMed ID: 29188358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. And now we have the AUGUSTUS … How will it impact on antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention?
    Rubboli A
    Eur J Intern Med; 2019 Jul; 65():1-3. PubMed ID: 31130303
    [No Abstract]   [Full Text] [Related]  

  • 23. Dual antithrombotic plus adjunctive antiinflammatory therapy to improve cardiovascular outcome in atrial fibrillation patients with concurrent acute coronary syndrome: A triple-pathway strategy.
    Chi G; Jamil A; Radulovic M; Jamil U; Balouch MA; Marszalek J; Karimi Z; Pahlavani S; Jafarizade M; Shaukat H; Kumar S; Kalayci A
    Med Hypotheses; 2018 May; 114():40-44. PubMed ID: 29602462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of thromboembolism in the patient with acute coronary syndrome and atrial fibrillation: the clinical dilemma of triple therapy.
    Fitchett D; Verma A; Eikelboom J; Madan M; Cohen E; Bell A; Dorian P
    Curr Opin Cardiol; 2014 Jan; 29(1):1-9. PubMed ID: 24284976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Managing antithrombotic therapy in patients with both atrial fibrillation and coronary heart disease.
    Thompson PL; Verheugt FW
    Clin Ther; 2014 Sep; 36(9):1176-81. PubMed ID: 25234549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Triple antithrombotic therapy for atrial fibrillation and coronary stents.
    Shmyr D; Van der Merwe V; Yakiwchuk E; Barry A; Kosar L
    Can Fam Physician; 2017 May; 63(5):375-381. PubMed ID: 28500198
    [No Abstract]   [Full Text] [Related]  

  • 27. More, More, More: Reducing Thrombosis in Acute Coronary Syndromes Beyond Dual Antiplatelet Therapy-Current Data and Future Directions.
    Spinthakis N; Farag M; Rocca B; Gorog DA
    J Am Heart Assoc; 2018 Jan; 7(3):. PubMed ID: 29374045
    [No Abstract]   [Full Text] [Related]  

  • 28. [Antithrombotic treatment in acute coronary syndrome].
    Darius H; Rupprecht HJ; Genth-Zotz S; Wittlinger T; Zotz R
    Dtsch Med Wochenschr; 2014 Jan; 139 Suppl 1():S17-22. PubMed ID: 24446037
    [No Abstract]   [Full Text] [Related]  

  • 29. Development of New Antithrombotic Regimens for Patients with Acute Coronary Syndrome.
    George S; Onwordi ENC; Gamal A; Zaman A
    Clin Drug Investig; 2019 Jun; 39(6):495-502. PubMed ID: 30972665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current Antithrombotic Therapy: Beyond Coronary Artery Disease.
    Mystakidi VC; Oikonomou E; Tousoulis D
    Curr Pharm Des; 2020; 26(23):2683-2685. PubMed ID: 32586236
    [No Abstract]   [Full Text] [Related]  

  • 31. [Impact of different antithrombotic therapy strategy on prognosis in coronary heart disease patients combining with atrial fibrillation: a meta analysis].
    Yuan C; Zhong L; Huang RC
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jun; 45(6):526-535. PubMed ID: 28648031
    [No Abstract]   [Full Text] [Related]  

  • 32. [Recent advances in antithrombotic therapy for patients with coronary artery disease undergoing percutaneous coronary intervention].
    Liu HW; Han YL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Feb; 49(2):108-110. PubMed ID: 33611894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute Coronary Syndromes and Atrial Fibrillation.
    Foussas S
    Hellenic J Cardiol; 2015; 56(6):527-8. PubMed ID: 26685301
    [No Abstract]   [Full Text] [Related]  

  • 34. Antithrombotic therapy: triple therapy or triple threat?
    Mega J; Carreras ET
    Hematology Am Soc Hematol Educ Program; 2012; 2012():547-52. PubMed ID: 23233633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gender differences in anticoagulation and antithrombotic therapy.
    Rauch U
    Handb Exp Pharmacol; 2012; (214):523-42. PubMed ID: 23027465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Difficult decision making in the management of patients with atrial fibrillation and acute coronary syndrome or invasive cardiovascular interventions: new recommendations for daily practice.
    Boriani G; Lane DA; Windecker S; Huber K; Kirchhof P; Lip GY
    Europace; 2015 Sep; 17(9):1319-22. PubMed ID: 25678602
    [No Abstract]   [Full Text] [Related]  

  • 37. Major Bleeding Rates in Atrial Fibrillation Patients on Single, Dual, or Triple Antithrombotic Therapy.
    van Rein N; Heide-Jørgensen U; Lijfering WM; Dekkers OM; Sørensen HT; Cannegieter SC
    Circulation; 2019 Feb; 139(6):775-786. PubMed ID: 30586754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in Antiplatelet and Anticoagulant Therapies for NSTE-ACS.
    Badjatiya A; Rao SV
    Curr Cardiol Rep; 2019 Jan; 21(1):3. PubMed ID: 30637536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence, Management, and Long-Term (6-Year) Outcomes of Atrial Fibrillation Among Patients Receiving Drug-Eluting Coronary Stents.
    Choi HI; Ahn JM; Kang SH; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
    JACC Cardiovasc Interv; 2017 Jun; 10(11):1075-1085. PubMed ID: 28527773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Current and future therapies for prophylaxis of thromboembolism in atrial fibrillation].
    Geisler T; Gawaz M
    MMW Fortschr Med; 2011 Apr; 153(15):27-30; quiz 31. PubMed ID: 21667556
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.